KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
KDNY
Delisted
KDNY was delisted on the 10th of August, 2023.
102 hedge funds and large institutions have $138M invested in Chinook Therapeutics, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 42 increasing their positions, 20 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
102
Holders Change
+17
Holders Change %
+20%
% of All Funds
2.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
42
Reduced
20
Closed
4
Calls
$274K
Puts
$3K
Net Calls
+$271K
Net Calls Change
+$175K
Top Buyers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$7.72M |
| 2 |
Renaissance Technologies
New York
|
+$3.16M |
| 3 |
TA
Teachers Advisors
New York
|
+$2.35M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$2.18M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$2.05M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$15.8M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$6.69M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.22M |
| 4 |
BlackRock
New York
|
-$1.27M |
| 5 |
Morgan Stanley
New York
|
-$1.02M |
